State Street Corp Neuro Metrix, Inc. Transaction History

State Street Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$2.81 - $5.5 $2,529 - $4,950	900 Added 5.21%	18,170 $67,000
Q4 2021 Feb 14, 2022	BUY	$5.02 - $9.82 $34,136 - $66,776	6,800 Added 64.95%	17,270 $87,000
Q3 2021 Nov 15, 2021	BUY	$3.23 - $24.73 $33,818 - $258,923	10,470 New	10,470 $106,000

320

Ticker NURO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 7,757,230
Market Cap $31.3M
Description
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to e...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.